Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND) | MicrobiomeTrials← Back to trialsNCT07389460
Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-04-07Est. Completion: 2027-12-31
Enrollment target: 820 participants Locations- The First Hospital of Lanzhou University, Lanzhou, Gansu, China
- The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
- Henan Provincial People's Hospital, Zhengzhou, Henan, China
- Loudi Central Hospital, Loudi, Hunan, China
- The Second Hospital of Dalian Medical University, Dalian, Liaoning, China
- Qinghai Provincial People's Hospital, Xining, Qinghai, China
- First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China
- Shanxi Cardiovascular Hospital, Taiyuan, Shanxi, China
- The First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang Uygur Autonomous Region, China
- Xuanwu Hospital Capital Medical University, Beijing, China
Other microbiome trials you might be interested in
Ischemic Stroke
In 2015, five randomized trials showed efficacy of endovascular thrombectomy over standard medical care in patients with…
Shenyang, ChinaEst. completion Jun 30, 2028
Ischemic StrokeSmall Vessel Cerebrovascular DiseaseCholesterol, LDLSecondary PreventionCardiovascular Diseases
Lipid-lowering therapy constitutes a cornerstone of secondary prevention in ischemic stroke; however, current stroke gui…
Ansan, South KoreaEst. completion Sep 2030
Nonvalvular Atrial Fibrillation
This prospective, open-label, multicenter randomized controlled trial will compare two preprocedural imaging assessment …
Shanghai, ChinaEst. completion Sep 1, 2028